We are live on ! Find out more
PC

Pier Capital Portfolio holdings

AUM $755M
1-Year Est. Return 94.38%
This Fund
S&P 500
This Quarter Est. Return
+9.56%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$710M
AUM Growth
+$37.4M
Cap. Flow
-$2.85M
Cap. Flow %
-0.4%
Top 10 Hldgs %
14.99%
Holding
143
New
16
Increased
49
Reduced
51
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 28.1%
2 Healthcare 23.07%
3 Industrials 18.2%
4 Consumer Discretionary 13.08%
5 Financials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BROS icon
76
Dutch Bros
BROS
$8.93B
$5.37M 0.76%
167,698
+40,171
+31% +$1.42M
AZEK
77
DELISTED
The AZEK Co
AZEK
$5.33M 0.75%
113,870
-60,881
-35% -$2.61M
AEHR icon
78
Aehr Test Systems
AEHR
$4.02B
$5.3M 0.75%
412,077
+103,144
+33% +$1.49M
PCOR icon
79
Procore
PCOR
$8.81B
$4.99M 0.7%
80,893
-42,712
-35% -$2.62M
ROIV icon
80
Roivant Sciences
ROIV
$26.2B
$4.96M 0.7%
429,908
+4,821
+1% +$54.9K
DNLI icon
81
Denali Therapeutics
DNLI
$4.04B
$4.9M 0.69%
168,082
+2,596
+2% +$64.3K
BE icon
82
Bloom Energy
BE
$69.6B
$4.88M 0.69%
461,744
+4,082
+0.9% +$48.4K
ITCI
83
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$4.8M 0.68%
65,560
+1,056
+2% +$79.4K
CLS icon
84
Celestica
CLS
$43.8B
$4.76M 0.67%
93,055
+335
+0.4% +$17.3K
APPF icon
85
AppFolio
APPF
$6.97B
$4.69M 0.66%
19,924
-18,201
-48% -$4.26M
MMS icon
86
Maximus
MMS
$2.94B
$4.62M 0.65%
49,639
-224
-0.4% -$20K
VERA icon
87
Vera Therapeutics
VERA
$2.08B
$4.57M 0.64%
+103,463
New +$3.93M
GTLB icon
88
GitLab
GTLB
$7.32B
$4.5M 0.63%
87,328
-22,702
-21% -$1.13M
ALAB icon
89
Astera Labs
ALAB
$56B
$4.34M 0.61%
82,916
+54,048
+187% +$2.54M
IMAX icon
90
IMAX
IMAX
$2.81B
$4.22M 0.59%
+205,811
New +$4.05M
COCO icon
91
Vita Coco
COCO
$3.85B
$4.07M 0.57%
143,744
-148,329
-51% -$3.94M
ARDT
92
Ardent Health
ARDT
$1.57B
$4.04M 0.57%
+219,827
New +$3.88M
MRVI icon
93
Maravai LifeSciences
MRVI
$861M
$3.95M 0.56%
475,852
-2,503
-0.5% -$21.6K
GH icon
94
Guardant Health
GH
$22.2B
$3.63M 0.51%
158,429
+42,575
+37% +$1.21M
CFLT
95
DELISTED
Confluent
CFLT
$3.59M 0.51%
175,943
-93,624
-35% -$2.1M
GDRX icon
96
GoodRx Holdings
GDRX
$1.27B
$3.26M 0.46%
+469,547
New +$3.69M
IMCR icon
97
Immunocore
IMCR
$1.77B
$2.57M 0.36%
82,480
+1,174
+1% +$42.7K
ELF icon
98
e.l.f. Beauty
ELF
$5.47B
$2.33M 0.33%
21,331
-28,871
-58% -$4.53M
LIND icon
99
Lindblad Expeditions
LIND
$2.24B
$2.1M 0.3%
227,316
-539,041
-70% -$5.01M
GOOS
100
Canada Goose Holdings
GOOS
$844M
$2.06M 0.29%
+164,141
New +$1.86M

Similar funds

Pier Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Pier Capital held 143 positions worth $710M, up 5.6% from $672M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Pier Capital's Q3 2024 filing shows 16 new, 49 increased, 51 reduced and 10 closed positions. Its largest new stake was Nextpower Inc: 205,983 shares worth $7.72M. The largest sale was Onto Innovation, an estimated $9.84M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Pier Capital's largest Q3 2024 buy was Nextpower Inc: 205,983 shares worth $7.72M.
  • Pier Capital added most to Axcelis in Q3 2024, an estimated $4.89M increase.
  • Pier Capital's biggest Q3 2024 reduction was Advanced Drainage Systems, cutting an estimated $7.92M.
  • Pier Capital fully exited Onto Innovation in Q3 2024, selling an estimated $9.84M.
  • Pier Capital's ten largest holdings make up 15% of its $710M portfolio in Q3 2024.
  • Pier Capital opened 16 new positions and closed 10 in Q3 2024.
  • Pier Capital's portfolio value rose 5.6% quarter-over-quarter to $710M.

Based on Pier Capital's 13F filing for Q3 2024, filed 15 Nov 2024.